| mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.06 |
| mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.06 |
| mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
0.32 |
0.06 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.06 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.06 |
| mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.06 |
| mRNA |
BRD4132 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.06 |
| mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.06 |
| mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.06 |